Changes in motor units closely reflect disease severity in people with spinal muscular atrophy (SMA), suggesting potential ...
QRL-101, an oral small molecule being developed by QurAlis, was safe and reduced nerve-cell overactivity in ALS patients in ...
A new study finds that restoring the protein SV2 in a genetic form of ALS can correct abnormalities in transmission and even prevent cells from dying, providing a new target for future therapies.
Patients with amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig's disease, lose muscle control as nerve cells or neurons in the brain and spinal cord degenerate and can no longer send ...
Hosted on MSN
Study unveils mechanisms driving axonal accumulation of TDP-43 and associated nerve damage in ALS
"To investigate the mechanisms driving local TDP-43 accumulation, we combined human ALS biopsies, transgenic mouse models, and neuron–muscle co-cultures grown in microfluidic chambers that allow us to ...
A groundbreaking drug candidate found to protect nerve cells damaged by motor neuron disease (MND), could offer new hope to ...
WASHINGTON, Tuesday, April 28, 2020 -- Biological robots, or biobots, draw inspiration from natural systems to mimic the motions of organisms, such as swimming or jumping. Improvements to biobots to ...
PHILADELPHIA - Patients with amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig's disease, lose muscle control as nerve cells or neurons in the brain and spinal cord degenerate and can no ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback